Source: ValueWalk

Gen9: The Top 11 Visual Capitalists In Biotechnology

This week started off with a bang for the healthcare industry as two VC-backed biotechs completed exits. Bioinformatics company Spiral Genetics was purchased by Omicia and Gen9, which specializes in the synthesis and assembly of DNA constructs, was acquired by [...]The post The Top 11 Visual Capitalists In Biotechnology appeared first on ValueWalk.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kevin Munnelly's photo - President & CEO of Gen9

President & CEO

Kevin Munnelly

CEO Approval Rating

63/100

Read more